SymbolFEED
NameNANOVIBRONIX, INC.
SectorHEALTH CARE
RegionNorth America
IndustryIndustrial Specialties
Address525 EXECUTIVE BOULEVARD, ELMSFORD, New York, 10523, United States
Telephone+1 914 233-3004
Fax
Email
Websitehttps://www.nanovibronix.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001326706
Description

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Additional info from NASDAQ:
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

2026-05-08 13:15

ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

Read more
2026-05-07 12:07

ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

Read more
2026-04-20 12:30

ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network

Read more
2026-04-17 21:10

Glibert Christian Michael 🟢 acquired 0 shares of ENvue Medical, Inc. (FEED) Transaction Date: Apr 15, 2026 | Filing ID: 000005

Read more
2026-04-17 17:58

New Form SCHEDULE 13D/A - ENvue Medical, Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0002111050-26-000004 <b>Size:</b> 6 KB

Read more
2026-04-16 13:00

ENvue Issues Stockholder Letter & Provides Corporate Update

Read more
2026-04-15 18:20

New Form 10-K - ENvue Medical, Inc. <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0001493152-26-016871 <b>Size:</b> 12 MB

Read more
2026-03-24 12:07

ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39

Read more